Stock Scorecard



Stock Summary for Stryker Corp (SYK)

Total Score

16 out of 29

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for SYK

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for SYK

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for SYK

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for SYK

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Financial Details for SYK

Company Overview

Company Name Stryker Corp
Country USA
Description Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
Sector Name LIFE SCIENCES
Industry Name SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Most Recent Quarter 9/30/2022
Next Earnings Date 1/25/2023

Stock Price History

Last Day Price 243.11
Last Day Volume 0
Average Daily Volume 1,600,904
52-Week High 277.79
52-Week Low 188.20
Last Price to 52 Week Low 29.18 %

Valuation Measures

Trailing PE 37.81
Industry PE 131.57
Sector PE 93.33
5-Year Average PE 27.73
Free Cash Flow Ratio 61.39
Industry Free Cash Flow Ratio 34.60
Sector Free Cash Flow Ratio 37.81
Book Value Per Share Most Recent Quarter 43.50
Price to Book Ratio 5.22
Industry Price to Book Ratio 5.52
Sector Price to Book Ratio 15.40
Price to Sales Ratio Twelve Trailing Months 5.13
Industry Price to Sales Ratio Twelve Trailing Months 8.62
Sector Price to Sales Ratio Twelve Trailing Months 25.28

Share Statistics

Total Shares Outstanding 378,430,000
Market Capitalization 92,000,117,300
Institutional Ownership 0.00 %

Dividends

Ex-Dividend Date 9/29/2022
Last Dividend Amount 0.70
Current Dividend Amount 0.70
Dividend Aristocrat? False
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00 %
Trailing Annual Dividend Rate 2.78
Trailing Annual Dividend Yield 1.22 %
5-Year Average Dividend Yield 0.00 %
5-Year Dividend Payments Count 20
Dividend Payout Ratio 0.00 %

Income Statement

Quarterly Earnings Growth YOY 87.70 %
Annual Earnings Growth 24.70 %
Reported EPS Past Year 6.34
Reported EPS Prior Year 9.09
Net Income Twelve Trailing Months 2,457,000,000
Net Income Past Year 1,994,000,000
Net Income Prior Year 1,599,000,000
Quarterly Revenue Growth YOY 7.70 %
5-Year Revenue Growth 8.28 %

Balance Sheet

Total Cash Per Share 3.96
Total Cash Most Recent Quarter 1,497,000,000
Total Cash Past Year 3,019,000,000
Total Cash Prior Year 3,024,000,000
Net Cash Position Most Recent Quarter 1,489,000,000
Net Cash Position Past Year -9,580,000,000
Long Term Debt Past Year 12,599,000,000
Long Term Debt Prior Year 14,131,000,000
Total Debt Most Recent Quarter 8,000,000
Equity to Debt Ratio Past Year 0.54
Equity to Debt Ratio Most Recent Quarter 1.00
Current Ratio Most Recent Quarter 2.04
Total Stockholder Equity Past Year 14,877,000,000
Total Stockholder Equity Prior Year 13,084,000,000
Total Stockholder Equity Most Recent Quarter 16,463,000,000

Options

Put/Call Ratio 0.24
Has Options Options Chain
Liquidity Rating

Technical Analysis

MACD 3.98
MACD Signal 2.85
20-Day Bollinger Lower Band 244.46
20-Day Bollinger Middle Band 251.37
20-Day Bollinger Upper Band 258.27
Beta 0.99
RSI 63.88
50-Day SMA 231.16
200-Day SMA 218.35

System

Modified 12/4/2022 4:50:24 AM